The survival impact of postoperative complications after curative resection in patients with esophageal squamous cell carcinoma: propensity score-matching analysis

被引:10
|
作者
Yamamoto, Manabu [1 ,2 ]
Shimokawa, Mototsugu [3 ]
Yoshida, Daisuke [2 ]
Yamaguchi, Shohei [2 ]
Ohta, Mitsuhiko [2 ]
Egashira, Akinori [2 ]
Ikebe, Masahiko [2 ]
Morita, Masaru [2 ]
Toh, Yasushi [2 ]
机构
[1] Fukuoka Sanno Hosp, Dept Surg, Sawara Ku, 3-6-45 Momochi Hama, Fukuoka 8140001, Japan
[2] Natl Kyushu Canc Ctr, Dept Gastroenterol Surg, Minami Ku, 3-1-1 Notame, Fukuoka 8111395, Japan
[3] Yamaguchi Univ, Dept Biostat, Grad Sch Med, I-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan
关键词
Esophageal cancer; Postoperative complications; Survival; Propensity matching; LONG-TERM SURVIVAL; MINIMALLY INVASIVE ESOPHAGECTOMY; SURGICAL COMPLICATIONS; GASTROESOPHAGEAL JUNCTION; PROGNOSTIC-SIGNIFICANCE; CANCER; MORTALITY; OUTCOMES; SURGERY; ADENOCARCINOMA;
D O I
10.1007/s00432-020-03173-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose The relationship between postoperative complications and long-term survival after surgery for esophageal squamous cell carcinoma (ESCC) is controversial. Method A total of 210 patients with ESCC who underwent subtotal esophagectomy with a reconstructed gastric tube were investigated according to the development of postoperative complications. The associations of age, gender, T and N factors, and pStage with grade 0-2 complications (NSC) and grade 3 and higher complications (SC) were compared by propensity score-matching analysis. Fifty-one pairs of NSC and SC groups were selected for the final analysis. We divided 102 patients between the NSC and SC groups or between the no pulmonary complication (NPC) and the pulmonary complication (PC) groups. The overall survival (OS) and disease-free survival (DFS) were determined by the Kaplan-Meier method and were compared by log-rank tests. Possible predictors of OS and DFS were subjected to univariate analysis and multivariate Cox proportional hazard regression analysis. Results The propensity score matching revealed that the 5-year OS and DFS of the NSC group were not different from those of the SC group. However, the 5-year OS of the PC group was significantly worse than that of the NPC group, while no significant differences were observed in the DFS between the PC and NPC groups. In the multivariate analysis, UICC pStage, pulmonary complication, and American Heart Association (AHA) classification for OS and UICC pStage for DFS were significant prognostic factors. Conclusion The OS and DFS did not differ in patients with or without severe postoperative complications. However, postoperative pulmonary complications were independent predictors of poorer OS, but not DFS, in patients who underwent R0 resection for ESCC.
引用
收藏
页码:1351 / 1360
页数:10
相关论文
共 50 条
  • [41] Postoperative Infectious Complications Impact Long-Term Survival in Patients Who Underwent Hepatectomies for Colorectal Liver Metastases: a Propensity Score Matching Analysis
    Memeo, Riccardo
    de Blasi, Vito
    Adam, Rene
    Goere, Diane
    Laurent, Alexis
    de'Angelis, Nicola
    Piardi, Tullio
    Lermite, Emilie
    Herrero, Astrid
    Navarro, Francis
    Sa Cunha, Antonio
    Pessaux, Patrick
    JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (12) : 2045 - 2054
  • [42] The impact of adjuvant therapy on survival for node-negative esophageal squamous cell carcinoma: a propensity score-matched analysis
    Deng, Xuyang
    He, Wenwu
    Jiang, Yingchun
    Deng, Sijie
    Mao, Tianqin
    Leng, Xuefeng
    Luo, Qiyu
    Zheng, Kai
    Han, Yongtao
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (12)
  • [43] Huaier granule prolongs overall survival after curative resection of hepatocarcinoma carcinoma: A propensity score analysis
    Luo, Shaoju
    Hu, Hao
    JOURNAL OF ETHNOPHARMACOLOGY, 2023, 301
  • [44] Impact of Postoperative Complications on Long-term Survival After Resection for Rectal Cancer
    Mrak, Karl
    Eberl, Thomas
    Laske, Andreas
    Jagoditsch, Michael
    Fritz, Josef
    Tschmelitsch, Joerg
    DISEASES OF THE COLON & RECTUM, 2013, 56 (01) : 20 - 28
  • [45] Impact of metabolic syndrome on the survival of Chinese patients with resectable esophageal squamous cell carcinoma
    Wen, Y. -S.
    Huang, C.
    Zhang, X.
    Qin, R.
    Lin, P.
    Rong, T.
    Zhang, L. -J.
    DISEASES OF THE ESOPHAGUS, 2016, 29 (06) : 607 - 613
  • [46] Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
    Chang, Yi-Lin
    Cheng, Ya-Fu
    Chen, Hui-Shan
    Wu, Siao-Chi
    Hung, Wei-Heng
    Chen, Heng-Chung
    Huang, Chang-Lun
    Cheng, Ching-Yuan
    Wang, Bing-Yen
    PLOS ONE, 2022, 17 (10):
  • [47] The Postoperative Lymphocyte to Monocyte Ratio Change Predicts Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Resection
    Song, Qian
    Wu, Jun-zhou
    Jiang, Hui-fen
    Wang, Sheng
    Cai, Shu-nv
    DISEASE MARKERS, 2020, 2020
  • [48] Prognostic Significance of Prognostic Nutritional Index in Esophageal Squamous Cell Carcinoma Patients Undergoing Radical Radiotherapy: A Propensity Score Matching Analysis
    Zhao, Yan
    Shen, Wenbin
    Song, Chunyang
    Su, Jingwei
    Wu, Peiwen
    Wang, Xuan
    Yan, Ke
    Xu, Jinrui
    Zhu, Shuchai
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (06): : 2095 - 2104
  • [49] Selection of the surgical approach for patients with cStage IA lung squamous cell carcinoma: A population-based propensity score matching analysis
    Shao, Shengteng
    Song, Guisong
    Wang, Yuanyong
    Yi, Tengfei
    Li, Shuo
    Chen, Fuhui
    Li, Yang
    Liu, Xiaotong
    Han, Bin
    Liu, Yuhong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [50] Epidemiology, Treatment, and Outcome of Pancreatic Squamous Cell Carcinoma and Pancreatic Adenocarcinoma: A Propensity Score-Matching Analysis Based on SEER-Database
    Wang, Yuqing
    Zhou, Yuwen
    Chen, Yueyun
    Xia, Ruolan
    Liu, Jiyan
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21